why choose us

Clinical Trials Search

Showing 20,750 of 132,963 result(s)
Comparing Message-based Psychotherapy to Once-weekly, Video-based Psychotherapy for Moderate Depression and Anxiety

Status: Completed

Condition: Depression
Anxiety

Interventions: Interventional

Date: 2022-07-18

Operant H-reflex Down-conditioning of Rectus Femoris in Post-stroke Stiff Knee Gait

Status: Completed

Condition: Training

Interventions: Interventional

Date: 2022-07-18

Comparison of Surgical Approaches in Reducing Mandibular Angle Fracture

Status: Completed

Condition: Fractures, Bone
Mandibular Fractures

Interventions: Interventional

Date: 2022-07-18

Global Cardiovascular Risk Consortium

Status: Completed

Condition: Cardiovascular Diseases
Heart Diseases
Coronary Disease
Myocardial Infarction
An

Interventions: Not Provided

Date: 2022-07-18

the Optimal Surveillance Frequency for Stage II/III Gastric Cancer

Status: Completed

Condition: Gastric Cancer

Interventions: Not Provided

Date: 2022-07-18

Bioequivalence Study of 8 mg Perindopril Tert-butylamine / 2.5 mg Indapamide Tablets Versus 10 mg Perindopril Arginine / 2.5 mg Indapamide Film-coated Tablets in Healthy Volunteers

Status: Completed

Condition: Randomized, Open-label, Single-dose, Two-sequence, Two-period, Crossover, Comparative, Oral Bioequiv

Interventions: Interventional

Date: 2022-07-18

Vivity IOL: Emmetropia Compared to Monovision.

Status: Active, not recruiting

Condition: Presbyopia

Interventions: Interventional

Date: 2022-07-18

Caplacizumab and Immunosuppressive Therapy Without Firstline Therapeutic Plasma Exchange in Adults With Immune-mediated Thrombotic Thrombocytopenic Purpura

Status: COMPLETED

Condition: Thrombotic Thrombocytopenic Purpura

Interventions: Lyophilized powder for solution for injection.

Date: 2022-07-18

Effects of Immulina TM Supplements With PASC Patients

Status: COMPLETED

Condition: Post Acute COVID-19 Syndrome

Interventions: Immulina TM is a highly standardized extract derived from various preparations of Spirulina, a cyanobacterium, marketed as a dietary supplement and ha

Date: 2022-07-18

A Study of MK-2214 in Adults With Mild Cognitive Impairment or Mild-to-Moderate Alzheimer's Disease (MK-2214-002)

Status: COMPLETED

Condition: Alzheimer Disease

Interventions: MK-2214 in escalating doses as an IV infusion on Days 1, 29, and 57

Date: 2022-07-18